These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19706144)

  • 1. Combination therapy using verteporfin and ranibizumab; optimizing the timing in the CAM model.
    Debefve E; Pegaz B; Ballini JP; van den Bergh H
    Photochem Photobiol; 2009; 85(6):1400-8. PubMed ID: 19706144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
    Husain D; Kim I; Gauthier D; Lane AM; Tsilimbaris MK; Ezra E; Connolly EJ; Michaud N; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW
    Arch Ophthalmol; 2005 Apr; 123(4):509-16. PubMed ID: 15824225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.
    Kourlas H; Abrams P
    Clin Ther; 2007 Sep; 29(9):1850-61. PubMed ID: 18035187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane.
    Nowak-Sliwinska P; van Beijnum JR; van Berkel M; van den Bergh H; Griffioen AW
    Angiogenesis; 2010 Dec; 13(4):281-92. PubMed ID: 20842454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
    Brown DM; Michels M; Kaiser PK; Heier JS; Sy JP; Ianchulev T;
    Ophthalmology; 2009 Jan; 116(1):57-65.e5. PubMed ID: 19118696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid.
    Kim IK; Husain D; Michaud N; Connolly E; Lane AM; Durrani K; Hafezi-Moghadam A; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):357-63. PubMed ID: 16384985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verteporfin photodynamic therapy and anti-angiogenic drugs: potential for combination therapy in exudative age-related macular degeneration.
    Kaiser PK
    Curr Med Res Opin; 2007 Mar; 23(3):477-87. PubMed ID: 17355729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in aqueous vascular endothelial growth factor and pigment epithelium-derived factor after ranibizumab alone or combined with verteporfin for exudative age-related macular degeneration.
    Ahn JK; Moon HJ
    Am J Ophthalmol; 2009 Nov; 148(5):718-724.e1. PubMed ID: 19674731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravitreal ranibizumab in combination with verteporfin photodynamic therapy in neovascular macular degeneration].
    Soucek P; Soucková I
    Cesk Slov Oftalmol; 2008 Jul; 64(4):135-40. PubMed ID: 18780651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results.
    Antoszyk AN; Tuomi L; Chung CY; Singh A;
    Am J Ophthalmol; 2008 May; 145(5):862-74. PubMed ID: 18321465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration.
    Samkoe KS; Clancy AA; Karotki A; Wilson BC; Cramb DT
    J Biomed Opt; 2007; 12(3):034025. PubMed ID: 17614733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion.
    Nowak-Sliwinska P; Weiss A; van Beijnum JR; Wong TJ; Ballini JP; Lovisa B; van den Bergh H; Griffioen AW
    J Cell Mol Med; 2012 Jul; 16(7):1553-62. PubMed ID: 21880113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.
    Heier JS; Boyer DS; Ciulla TA; Ferrone PJ; Jumper JM; Gentile RC; Kotlovker D; Chung CY; Kim RY;
    Arch Ophthalmol; 2006 Nov; 124(11):1532-42. PubMed ID: 17101999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination photodynamic therapy and intravitreal ranibizumab in neovascular age-related macular degeneration in a North Indian population: a pilot study.
    Kumar A; Gopalakrishnan K; Sinha S
    Retina; 2008 Oct; 28(9):1296-301. PubMed ID: 18667951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
    Brown DM; Kaiser PK; Michels M; Soubrane G; Heier JS; Kim RY; Sy JP; Schneider S;
    N Engl J Med; 2006 Oct; 355(14):1432-44. PubMed ID: 17021319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial.
    Bressler NM; Chang TS; Fine JT; Dolan CM; Ward J;
    Arch Ophthalmol; 2009 Jan; 127(1):13-21. PubMed ID: 19139332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results.
    Kaiser PK; Brown DM; Zhang K; Hudson HL; Holz FG; Shapiro H; Schneider S; Acharya NR
    Am J Ophthalmol; 2007 Dec; 144(6):850-857. PubMed ID: 17949673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of verteporfin photodynamic therapy and ranibizumab: effects on retinal anatomy, choroidal perfusion and visual function in the protect study.
    Kiss CG; Simader C; Michels S; Schmidt-Erfurth U
    Br J Ophthalmol; 2008 Dec; 92(12):1620-7. PubMed ID: 19029163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration.
    Zuluaga MF; Mailhos C; Robinson G; Shima DT; Gurny R; Lange N
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1767-72. PubMed ID: 17389510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
    Lazic R; Gabric N
    Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.